Author:
D'Abronzo L S,Bose S,Crapuchettes M E,Beggs R E,Vinall R L,Tepper C G,Siddiqui S,Mudryj M,Melgoza F U,Durbin-Johnson B P,deVere White R W,Ghosh P M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference48 articles.
1. MacVicar GR, Hussain MH . Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer. Curr Opin Oncol 2013; 25: 252–260.
2. Wu Y, Chhipa RR, Cheng J, Zhang H, Mohler JL, Ip C . Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival. Anticancer Res 2010; 30: 3895–3901.
3. Fang Z, Zhang T, Dizeyi N, Chen S, Wang H, Swanson KD et al. Androgen receptor enhances p27 degradation in prostate cancer cells through rapid and selective TORC2 activation. J Biol Chem 2012; 287: 2090–2098.
4. Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ et al. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer 2005; 12: 119–134.
5. Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW . The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant 2008; 8: 2668–2673.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献